Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
A Randomised Phase 2b Study Comparing the Efficacy and Safety of Belotecan vs Topotecan as Monotherapy for Sensitive-Relapsed Small-Cell Lung CancerBr. J. Cancer 2020 Nov 16;[EPub Ahead of Print], JH Kang, KH Lee, DW Kim, SW Kim, HR Kim, JH Kim, JH Choi, HJ An, JS Kim, JS Jang, BS Kim, HT Kim
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.